Sanofi CEO: The enterprise AI shift will reshape pharma in 2026 | Fortune

Paul Hudson has been CEO of Sanofi since September 2019. Previously, he was CEO of Novartis Pharmaceuticals from 2016 to 2019. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and served as president, AstraZeneca US and executive vice president, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synth?labo UK.

Great Job Paul Hudson & the Team @ Fortune | FORTUNE for sharing this story.

Felicia Owens
Felicia Owenshttps://feliciaray.com
Happy wife of Ret. Army Vet, proud mom, guiding others to balance in life, relationships & purpose.

Latest articles

spot_img

Related articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Leave the field below empty!

spot_img
Secret Link